Introduction
Disruption of 14-3-3 protein expression and function has been recently implicated in Parkinson's disease (PD) pathogenesis. The 14-3-3 proteins are a highly conserved family of proteins found throughout the evolutionary scale and are implicated in many cellular functions, including transcription, metabolism, and apoptosis (Dougherty and Morrison, 2004; Mackintosh, 2004) . This protein family, which includes seven isoforms in mammals, is a key regulator of cell death and acts to promote cell survival through inhibition of many known proapoptotic factors (Porter et al., 2006; Masters and Fu, 2001 ). 14-3-3s have been shown to interact with several key proteins implicated in PD, including alpha-synuclein (αsyn), parkin, and leucine-rich repeat kinase 2 (LRRK2) (Dzamko et al., 2010; Li et al., 2011; Nichols et al., 2010; Ostrerova et al., 1999; Sato et al., 2006; Xu et al., 2002 ). 14-3-3s are a key hub of dysregulated proteins in a transcriptional analysis of PD patients (Ulitsky et al., 2010 ). 14-3-3s show homology to αsyn and coimmunoprecipitate with αsyn in normal brain (Ostrerova et al., 1999; Xu et al., 2002) . Coimmunoprecipitation of 14-3-3s with αsyn is increased in the substantia nigra (SN) of PD brains (Sato et al., 2006; Xu et al., 2002) , a predominant region involved in PD, and 14-3-3s colocalize with αsyn in Lewy Bodies (Berg et al., 2003; Kawamoto et al., 2002) . Four isoforms have been shown to colocalize with αsyn in Lewy bodies in human PD, including 14-3-3ε, γ, θ, and ζ (Berg et al., 2003) . We have previously shown that expression of several 14-3-3 isoforms is decreased with overexpression of wildtype human αsyn in neuroblastoma cells or transgenic mice (Yacoubian et al., 2008 (Yacoubian et al., , 2010 Ding et al., 2013) . Changes in 14-3-3θ and other isoforms are observed at the mRNA level in both the substantia nigra and cortex of an αsyn mouse model (Yacoubian et al., 2008 (Yacoubian et al., , 2010 ). 14-3-3s are also key interactors of wildtype LRRK2, and several PD-associated LRRK2 mutants have been shown to be unable to bind 14-3-3s (Dzamko et al., 2010; Li et al., 2011; Nichols et al., 2010) .
Because of 14-3-3s' anti-apoptotic role, we have previously hypothesized that disruption of 14-3-3s in PD could lead to the activation of cell death pathways that are normally inhibited by 14-3-3s. In support of this hypothesis, we have shown that overexpression of 14-3-3θ, ε, or γ reduced cell loss in response to the Parkinsonian toxins rotenone and 1-methyl-4-phenylpyridinium (MPP + ) in dopaminergic cell culture, while other isoforms showed variable effects (Yacoubian et al., 2010) . Human 14-3-3θ and the Caenorhabditis elegans 14-3-3 homologue ftt-2 also reduced cell loss in transgenic C. elegans that 
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